The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety of same day HD-MTX with induction therapy for DLBCL with concurrent CNS disease or as prophylaxis for high risk of CNS relapse.
 
Brett Barlow
No Relationships to Disclose
 
Haris Hatic
No Relationships to Disclose
 
Charles Douglas Bodine
No Relationships to Disclose
 
Amitkumar Mehta
Stock and Other Ownership Interests - Witty Health
Consulting or Advisory Role - Aileron Therapeutics; AstraZeneca; Bristol-Myers Squibb; Carevive; Incyte; Kite, a Gilead company; Kyowa Kirin International; Pharmacyclics; Rigel; Seagen; Spectrum Pharmaceuticals; TG Therapeutics
Speakers' Bureau - AstraZeneca; Gilead Sciences; Incyte; Kite, a Gilead company; Seagen; Spectrum Pharmaceuticals
Research Funding - ADC Therapeutics; ADC Therapeutics (Inst); Affimed Therapeutics; Aileron Therapeutics (Inst); Astex Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Carevive (Inst); Epizyme (Inst); Forty Seven (Inst); Gilead Sciences (Inst); incyte (Inst); Innate Pharma; Juno Therapeutics (Inst); Merck (Inst); oncotartis (Inst); Pharmacyclics/Janssen (Inst); Rhizen Pharmaceuticals; Roche/Genentech (Inst); Seagen (Inst); Takeda (Inst); TG Therapeutics
 
Gaurav Goyal
No Relationships to Disclose
 
Mayur Narkhede
Research Funding - Genmab (Inst); Roche/Genentech (Inst); TG Therapeutics (Inst)